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ABSTRACT 
 
THE ROLE OF CAMK-II IN SKELETAL MUSCLE FUNCTION AND SWIMMING  
 
BEHAVIOR IN ZEBRAFISH 
 
MINH PHI NGUYEN, B.S. 
 
A thesis submitted in partial fulfillment of the requirements for the degree of Master of  
 
Science at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2013 
 
Major Director: ROBERT M. TOMBES, Ph.D. 
Professor, Department of Biology 
 
Previous research showed mutations in muscle sarcoplasmic reticulum-bound 
calcium handler proteins cause swimming defects in embryonic zebrafish. CaMK-II is a 
highly conserved Ca2+/calmodulin-dependent protein kinase expressed in all vertebrates has 
been defined to activate and inactivate multiple Ca2+ handler proteins involved in excitation-
contraction coupling and relaxation of cardiac and skeletal muscle.  In this study, evidence is 
xi 
provided through pharmacological and genetic intervention that CaMK-II inhibition and 
overexpression causes swimming defects, particularly response to stimuli and swimming 
ability, reinforced by immunolocalization of skeletal muscle. Transient CaMK-II inactivation 
does not have any long-term defects to swimming behavior. Overexpression of wild-type, 
constitutively active, and dominant-negative CaMK-II-GFP in embryos tended to co-localize 
in fast muscle which led to defects in swimming behavior. This study concludes that 
inhibition or overexpression of CaMK-II in skeletal muscle diminishes normal swimming 
behavior specifically in response to mechanical stimulation and swimming ability.
1 
 
 
 
 
 
INTRODUCTION 
 
CaMK-II 
Calcium (Ca2+)/Calmodulin dependent kinase type II (CaMK-II) is a ubiquitously 
expressed multifunctional serine/threonine protein regulated by Ca2+ and Calmodulin. 
CaMK-II is an evolutionarily conserved protein encoded by four genes (α, β, γ, and δ) in 
mammals (Tombes et al., 2003). 
 CaMK-II is composed of up to twelve subunits. Each subunit is composed of an 
amino-terminal catalytic and regulatory domain, a central variable domain and a carboxy-
terminal oligomerization domain. The amino-terminal catalytic domain consists of 315-
amino acid and contains ATP- and calmodulin-binding sites (Schulman et al., 1992). The 
central variable domain is composed of 30-100 amino acid and is the site for alternative 
splicing to produce multiple splice variants (Tombes et al., 2003). The carboxy-terminus is 
made up of 135-amino-acids whose domain allows for the twelve monomers of CaMK-II to 
oligomerize and form a dodecameric protein.  CaMK-II is distinguished from other CaM 
kinases due to the ability to oligomerize and to autophosphorylate (Tombes et al., 2003). 
 
 
 
2 
CaMK-II skeletal muscle rationale 
In zebrafish, CaMK-II activity rises within two hours post fertilization. Seven 
zebrafish CaMK-II genes have been identified which all vary in spatial and temporal 
expression (Rothschild et al., 2007; Fransescatto et al., 2010).  There is one α gene (camk2a1), 
one β gene (camk2b1), two γ genes (camk2g1 and camk2g2), two δ genes (camk2d1 and 
camk2d2) and a non-kinase protein encoded by αKAP gene that can target the CaMK-II to 
the SR membrane (Rothschild et al., 2007; Fransescatto et al., 2010; Bayer et al., 1998).  
Although CaMK-II is mostly known for regulating neuronal processes within the brain, 
CaMK-II is widely expressed during early development of zebrafish, and has been shown to 
play a role at the Kupffer’s vesicle in left-right asymmetry (Francescatto et al., 2010), and in 
cardiac and pectoral fin development (Rothschild, et al., 2009). Due to the ubiquitous 
expression of CaMK-II, I believe CaMK-II plays a role in skeletal muscle development or 
function in zebrafish. In zebrafish, previous research found that β CaMK-II and δ CaMK-II 
are expressed in the central nervous system (CNS) as well in skeletal muscle. αKAP CaM-II, 
a membrane-targeted CaMK-II, is only detected in cardiac and skeletal muscle (Tombes et. 
al, 2003).  
 
Skeletal Muscle Overview 
Motor neurons release the neurotransmitter acetylcholine when activated at 
neuromuscular junctions (NMJs) and depolarize muscle membranes. In muscle, 
depolarization is sensed by voltage-dependent channels, such as dihydropyridine receptors 
(DHPR), and activates ryanodine receptors in the sarcoplasmic reticulum (SR) membrane to 
release Ca2+ from the SR into the cytosol. Increased cytosolic Ca2+ activates troponin C that 
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initiates actin/myosin sliding, thus contracting the muscles. Cytosolic Ca2+ levels are rapidly 
decreased by sarcoplasmic reticulum Ca2+-ATPase 1 (SERCA1), a Ca2+ pump expressed in 
skeletal muscle, which enables relaxation (Hirata et al., 2004). 
 
CaMK-II’s role in skeletal muscle 
CaMK-II plays a role in regulating synaptic transmission at the neuromuscular 
junctions. Mature neuromuscular junctions, a synapse that forms between motor neurons 
and skeletal muscle fibers, require maintenance of a high postsynaptic receptor density for 
efficient synaptic transmission (Valenzuela et al., 2010). In skeletal muscle, postsynaptic 
receptor density is maintained by the endocytic recycling of nicotinic acetylcholine receptors 
(nAChRs). CaMK-II activity has been shown to promote acetylcholine receptor (AChR) 
translocation to the surface of the membrane (Figure 1). The amount of surface-associated 
recycled nAChRs is reduced by inhibition of CaMK-II activity, whereas the number of 
nAChRs that accumulate intracellularly is increased compared with control (Valenuela 2010). 
CaMK-II phosphorylates several Ca2+ handling proteins in muscle including SR Ca2+ 
channels, ryanodine receptors (RYR), and phospholamban (PLB) (Maier et al., 2007; Sahoo 
et al., 2012; Sacchetto et al., 2005) (Figure 1). CaMK-II directly phosphorylates RYR, which 
allows for calcium to be released from the SR and into the sarcomere allowing for muscle 
contraction (Figure 1). The activity of the SERCA determines the rate of removal of calcium, 
which is regulated predominantly by sarcolipin in skeletal muscle and by phospholamban in 
mainly cardiac and some slow-twitch muscle (Sahoo et al., 2012). Dephosphorylation of PLB 
inhibits affinity to SERCA for Ca2+ and PLB phosphorylation relieves this inhibition and 
allows for muscle relaxation (Mattiazzi and Kranias, 2011). 
  
4 
 
 
 
 
 
EXPERIMENTAL APPROACH 
The zebrafish, Danio rerio, is a model organism used extensively in research as a 
model for many human diseases. Zebrafish have been used to study the formation of 
kidneys, cardiovascular development, immune systems and cancer (Beis and Stainier, 2006). 
Like other model organism such as Caenorhabditis elegans, the fruit fly, the frog Xenopus laevis 
and the mouse, the zebrafish conforms to the same fundamental body plan as humans, 
contains an equivalent to close to every human organ and the development of these organs 
utilizes some of the same key molecular pathways. This similarity between the organisms 
allows for gene function and manipulation in ways that can be applicable to human 
development and disease such as muscular dystrophy (Bassett and Currie, 2003). 
Previous research showed, that knock down of ryanodine receptor, CaMK-II 
phosphorylated protein, in zebrafish exhibited slow swimming and lack of striations in fast 
twitch skeletal muscle (Hirata et al., 2007). The zebrafish mutant accordion (acc) mutation, 
which harbors a mutation in SERCA, has also been shown to correlate with impaired Ca2+ 
re-uptake into the SR from the cytosol in mutant muscles and relaxation of skeletal muscle 
was five times slower than in wild-type siblings (Hirata et al., 2004). After 48 hours post 
fertilization (hpf) acc mutants exhibited morphological defects, the trunks were frequently 
bent and slow twitch muscle fibers were disturbed (Hirata et al., 2004).  
5 
Current research in CaMK-II focuses mainly on CaMK-II’s role in cardiac function 
and development. It has yet to be determined the connection between CaMK-II’s role in 
skeletal muscle and swimming behavior in model organisms particularly in zebrafish. 
Inhibition of CaMK-II has shown intracellular accumulation of nAChRs and neuromuscular 
synaptogenesis mutant zebrafish showed impaired motility. But the two processes have 
never been linked together by CaMK-II in zebrafish.  Due to CaMK-II’s multiple roles in 
sarcomeres and SR’s, it may be possible that any inhibition of CaMK-II itself may have 
similar or even greater behavioral and developmental defects in zebrafish skeletal muscle.  
In this study it was of particular interest to determine the effect of CaMK-II’s role in 
zebrafish skeletal muscle swimming behavioral response to stimuli and ability, additionally 
skeletal muscle development and function. I examined this in the following ways. Zebrafish 
embryos can be observed for behavioral swimming responses and ability by mechanical 
stimulation at 48hpf (Figure 2).  Pharmaceutical treatment with 2-[N-(hydroxythyl)-N-(4-
methoxybenzenelfonyl)] amino-N-(4-chrlorocinnamyl)-N-methylbenzylamine (KN-93), 
CaMK-II inhibitor, allowed for inhibition of CaMK-II activity at any of time point 
throughout the whole embryo during development. I examined the effects of overexpression 
of CaMK-II by microinjection of different CaMK-II-GFP-tagged complementary 
deoxyribonucleic acid (cDNA) constructs: K43A-dominant negative (DN), T287D 
constitutively active (CA), and wild-type (WT) allowed for observation of high expression of 
CaMK-II in the trunk of zebrafish embryos. The CaMK-II cDNA constructs were 
downstream of the β-actin promoter, meaning they would be ubiquitously expressed in the 
whole embryo. In order to isolate expression of CaMK-II in skeletal muscle cells and not 
other cells such as neuronal, it was of interest to localize CaMK-II expression in skeletal 
muscle by constructing a CaMK-II-GFP tagged under the control of the skeletal muscle 
6 
specific promoter, myogenin, to drive CaMK-II expression in exclusively skeletal muscle. 
Myogenin is a basic Helix-Loop-Helix transcription factor that plays key roles in myoblast 
specification and differentiation and is specifically expressed in developing somite and 
skeletal muscles in zebrafish embryos (Du et al., 2003). Myogenin promoter (0.8kb) has been 
shown to direct green fluorescence protein (GFP) in expression in the trunk and tail of 
zebrafish embryos (Du et al., 2003).   Fluorescent antibodies against fast-twitch (MF20) and 
slow-twitch (F59) skeletal muscles made it possible to observe any skeletal muscle 
developmental defects through confocal microscopy. Anti-acetylated α tubulin antibodies 
allowed the observation of any neuronal axon stability defects in muscle somites.  
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MATERIALS AND METHODS 
 
Zebrafish Strains and Care 
Wild-type (AB and AB Yoshi) zebrafish embryos were obtained through natural 
matings and raised at 28.5°C in the presence of 0.0003% PTU (1-phenyl-2-thiourea) to block 
pigmentation as described (Kimmel et al., 1995).  
 
KN-93 Drug Treatment 
CaMK-II activity was inhibited by pharmacological treatment with KN-93. Zebrafish 
embryos were incubated in 10 µM KN-93 diluted in embryo water. Embryos incubated with 
only embryo water served as the control. Embryos were not dechorionated prior to 
treatment. 
 
Vectors 
Skeletal muscle was targeted by injecting human chimeric CaMK-II: wild-type (WT), 
K43A dominant-negative (DN), and T287D constitutively active (CA) CaMK-II is linked to a 
β-actin promoter vector (Rothschild et al, 2009). 
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cDNA Injections of Zebrafish Embryos 
Wild-type, constitutively active, dominant-negative CaMK-II cDNA constructs were 
diluted to stock concentrations of 50ng/µl and 25ng/µl in danieau buffer.  Embryos were 
injected with 50pg or 25pg of one of the three CaMK-II-GFP cDNA constructs at the one- 
to four-cell stage (Kimmel et al., 1995). Embryos were assessed for GFP expression at 48hpf 
on a Nikon AZ100 stereo microscope mounted with a Nikon DS-FLi1 camera.   
 
Mechanical Touch Test 
Zebrafish embryos were dechorionated and mechanically stimulated with forceps in 
the trunk region at 48hpf (Hirata et al., 2007). Embryos were assessed for response to stimuli 
and swimming ability at 48hpf (Figure 2).  Swimming behavior was video recorded with a 
Nikon AZ stereo microscope with a DS-FLi1 camera and analyzed with NIS-Elements 
software.  
 
Immunolocalization 
Embryos were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS). 
Embryos were incubated with primary antibodies F59 (1:10), MF20 (1:10) mouse anti-
myosin, or anti-actylated α-tubulin (1:100) immunoglobulin gamma (IgG) followed by 
mouse anti-mouse Alexa568 (1:500) secondary antibodies purchased from Invitrogen.  
Primary antibodies were purchased from the Developmental Studies Hybridoma Bank at the 
University of Iowa. Embryos were imaged by confocal microscopy (Nikon C1 Plus two-
laser) on a Nikon E-600 compound microscope using a 40X dry objective. 
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Zebrafish Myogenin Promoter  
 Obtained cDNA construct of zebrafish myogenin promoter/GFP tagged from Dr. 
Shao Jun Du University of Maryland School of Medicine (Figure 3). 
 
Myogenin-CaMK-II-GFP tagged Vector Construction via Gateway Cloning 
Myogenin promoter was recombined with CaMK-II to create an injectable expression 
vector by using Multi-site Gateway system. The Gateway technology is a cloning technique 
that allows the generation of complex multiple gene segments as described (Fontes, 2013).  
Myogenin promoter gene sequence was flanked with att sites by a polymerase chain reaction 
(PCR) with primers attB4-forward and attB1R-reverse:  
B4:  GGGACAACTTTGTATAGAAAAGTTGGTCGACGGCCCGGGCTGGTA   
B1R: GGGGACTGCTTTTTTGTACAAACTTGGTCTTTGCTGGTTTAGAGTC.  
The PCR product underwent a BP clonase reaction to recombine into pDONR-P4-P1R 
vector. A multi-site LR clonase reaction recombined myogenin promoter (pDONR), p3E-
polyA vector, and one of three human chimeric CaMK-IIs (WT, CA, and DN) expression  
pENTR3C-P+delpA middle entry vectors into pDestTol2pA2-destination vector (final 
destination vector).  
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RESULTS 
 
Role of CaMK-II in embryonic swimming behavior using pharmacological treatment 
 The effects of CaMK-II inhibition on swimming can be determined using 
pharmacological treatment, which allows for temporal control of testing. I used KN-93, 
which is a compound that prevents the activation of CaMK-II and sustains it in an 
inactivated state (Tombes et al., 1995). Embryos were continuously treated with KN-93 
starting at 43hpf every few hours and then were assessed for swimming ability at 48hpf by a 
mechanical touch test (Figure 4). The swimming ability of embryos was categorized into 
three groups: normal swimming, impaired swimming, and no swimming. Embryos were 
considered to have normal swimming ability if they were able to demonstrate a full C-bend, a 
rapid bend of the tail followed by a counter bend and swimming away from the site of 
stimuli (McClenahan et al., 2012).  Embryos were considered to have impaired swimming if 
they did not demonstrate a full C-bend, did not demonstrate rapid bend of tail followed by 
counter bend away from stimuli. Impaired embryos varied in swimming patterns: 1) swam a 
short distance by quick twitches in the trunk and tail 2) swam in a circle by quick twitches or 
3) remained idle with a single or multiple twitches. Embryos were considered to have no 
swimming ability when they failed to demonstrate any bending of the trunk-and-tail.  
Embryonic swimming ability was scored on a scale of 1-3 (1 = no swimming, 2 = impaired 
11 
swimming, 3 = normal swimming). All statistical analyses were completed by unpaired t-test. 
Statistical significance was set at p < 0.05. The average scores of each time point were 3.00 ± 
0.00 for untreated, 1.92 ± 0.28 at 13hpf, 1.88 ± 0.39 at 23hpf, 1.79 ± 0.41 at 28hpf, 1.89 ± 
0.36 at 37hpf, and 1.95 ± 0.22 at 43hpf.  The average swimming ability score of KN-93 
treatment embryos at all time points (13-43hpf) were statistically significantly different from 
untreated embryos with all p-values < 0.001. It was found that over 80% of embryos (n = 
313) treated at all time points from 13hpf to 43hpf exhibited impaired swimming and/or no 
swimming ability. Continuous KN-93 treatment of embryos starting at any time point 
between 13-43hpf significantly inhibited embryonic normal swimming ability when tested at 
48hpf (Figure 4). 
 The next objective was to assess the ability of zebrafish to properly respond to 
mechanical stimuli. The ability of embryos to respond to stimuli was categorized into three 
groups: normal response, delayed response, and no response. Embryos were considered to 
have a normal response if embryos were able to immediately demonstrate any behavioral 
movement upon stimulation regardless of their ability to properly swim. Embryos were 
considered to have a delayed response if they did not respond behaviorally immediately to 
stimuli.  Delayed response embryos varied in behavior responses to stimuli in three ways: 1) 
responded after a few seconds upon initial stimulation 2) responded after a second 
stimulation a few seconds after the initial stimulation or 3) responded a few seconds after a 
sustained initial stimulation.   
To test reversibility of CaMK-II inhibition, Embryos were continuously treated with 
KN-93 starting at 43hpf (treated group, n = 20) or treated with KN-93 starting at 43hpf and 
washed out at 45hpf (wash group, n =28) (Figure 5). Assessment of response to mechanical 
stimuli and swimming ability was tested by touch test at 48hpf.  Embryonic response to 
12 
stimuli was scored from a scale of 1-3 (1 = no response, 2 = delayed response, and 3 = 
normal response). The average response to stimuli score for untreated embryos was a score 
of a 3.00 ± 0.00, treated embryos was a 2.75 ± 0.55, and washed embryos was a 2.82 ± 0.48. 
Continuously treated embryos did not show statistical significant difference in ability to 
respond to stimuli compared to untreated embryos with a p-value = 0.06.  The average score 
for embryos washed out at 45hpf did not show statistical significant difference in ability to 
respond to stimuli at 48hpf compared to treated embryos that were not washed at 45hpf 
with a p-value = 0.64. At least 80% of the embryos in the washout group and the treated 
group were able to show a normal response to mechanical stimuli (Figure 5). The evidence 
suggests that transient inactivation of CaMK-II from 43-45hpf does not have a significant 
long-term effect on zebrafish’s ability to have a proper behavioral response to mechanical 
stimuli.  
 The same embryos tested for responses to stimuli were assessed for swimming ability 
by touch test (Figure 6). The average swimming ability score for untreated embryos was 3 ± 
0, treated embryos was 1.95 ± 0.22, and washed embryos was 2.55 ± 0.58. It was found that 
the average swimming ability score for treated embryos was statistically significantly different 
from untreated embryos with a p-value < 0.001. Indicating there was a significant inhibition 
in swimming ability when continuously treated at 43hpf. But when KN-93 was washed out, 
the average swimming ability score of wash group embryos was a showed statistical 
significant difference when compared to treated embryos with a p-value <0.001. The result 
reveals that washing out KN-93 after two hours of treatment has significant recovery in 
swimming ability at 48hpf. Nearly 95% of embryos of the treated group showed impaired 
swimming ability and about 55% of embryos treated with KN-93 in the wash group 
exhibited normal swimming behavior (Figure 6). Untreated embryos typically were able to 
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show a strong burst of swimming away from the stimuli and could demonstrate full lateral 
flexing of the trunk. Embryos with impaired swimming failed to demonstrate full C-bend. It 
should be noted that although some fish in the wash group were able to show normal 
swimming at 48hpf, the fish did not have the same swimming burst away from the stimuli as 
untreated embryos. It should be noted by 72hpf the embryos in the wash group showed 
normal swimming ability in combination to burst swimming. Treatment with KN-93 from 
43-45hpf does not have a significant inhibition of normal swimming at 48hpf and does not 
have a long-term effect on embryonic swimming ability. The evidence suggests inactivation 
of CaMK-II by KN-93 does have an effect on zebrafish’s ability to properly swim; any 
defects in swimming ability are due to functional and not developmental reasons.  
 
Role of CaMK-II in swimming ability using genetic approaches 
Pharmacological treatment of embryos was caused swimming deficiencies. The next 
goal of the study was to determine whether genetic disruption caused similar behavioral 
defects. In these studies I wanted to observe the effects of overexpression of CaMK-II on 
swimming behavior. Embryos were injected with wild-type CaMK-II-GFP (green 
fluorescence protein) tagged cDNA linked to a ubiquitous expression promoter at the one-
to-four cell stage and assessed for response to mechanical stimuli and swimming ability at 
48hpf.  These were not injected with transposase so all embryos developed phenotypically 
normal and mosaic expression was detected by GFP in the trunk and tail at 48hpf (Figure 
7c-f).  The average response to stimuli score for wild-type overexpression was 2.90 ± 0.32 
for danieau buffer, 2.25 ± 0.59 for 25pg, and 2.29 ± 0.81 for 50pg. The statistical results 
show that there was a significant difference between both 25pg and 50pg of overexpressed 
wild-type CaMK-II compared to danieau buffer injected embryonic response to stimuli with 
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both p-values <0.001.  The evidence found that over 40% of 25pg (n = 57) and 30% of 
50pg (n = 44) overexpressed wild-type CaMK-II embryos showed a delayed response and 
20% of both 25pg and 50pg of embryos showed no response to mechanical stimuli (Figure 
8).  The evidence suggests ubiquitous overexpression of wild-type CaMK-II significantly 
inhibits the ability of embryos to respond to stimuli. 
 Embryos were assessed for swimming ability at 48hpf by the touch test. The average 
swimming ability score when wild-type CaMK-II is overexpressed was 2.90 ± 0.32 for 
danieau buffer, 2.24 ± 0.59 for 25pg, and 1.90 ± 0.58 for 50pg. The statistical results show 
that there is a significant difference between both 25pg and 50pg wild-type CaMK-II 
compared to danieau buffer injected embryos with both p-values <0.001. The results 
indicate that nearly 50% of embryos with 25ng (n = 57) or 50ng (n = 44) wild-type-CaMK-II 
cDNA showed impaired swimming ability and 20% in both 25pg and 50pg of WT-CaMK-II 
had no swimming ability (Figure 9).  The evidence showed overexpression of wild-type 
CaMK-II had a statistically significant impaired effect on embryonic response to stimulation 
and swimming ability, conceivably by skeletal muscle function. 
 After showing overexpression of WT-CaMK-II in embryos display impaired 
swimming behavior, the next objective was to possibly show similar or a more severe 
phenotype when embryos overexpressed constitutively active (CA) CaMK-II.  Constitutively 
active CaMK-II is always active and made by mutating Thr287 to Asp287 (T287D). Embryos 
were injected with T287D-CaMK-II-GFP tagged cDNA linked to a ubiquitous promoter at 
the one-to-four cell stage and assessed for ability to respond to mechanical stimuli and 
swimming ability by touch test at 48hpf. Like WT-CaMK-II, all embryos developed 
phenotypically normal and showed mosaic GFP expression in the trunk and tail at 48hpf 
(Figure 7g-j).  The average response to stimuli scores for overexpression of CA-CaMK-II 
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was 2.12 ± 0.71 for 25pg and 1.87 ± 0.86 for 50pg were found to be statistically significantly 
different from the control injection of danieau buffer score of 2.90 ± 0.32 with both p-
values < 0.001. It was found that nearly 50% of 25pg (n = 51) injected embryos showed a 
delayed response but when the concentration increased to 50pg/nl (n = 39) the percentage 
of embryos exhibiting delayed response dropped to 25% (Figure 10). At the same time, 
about 20% of 25pg injected embryos showed no response and when injected with 50pg the 
percentage of embryos showing no response increased to 40%.  We conclude, 
overexpression of constitutively active CaMK-II has a statistically significant inhibition of 
normal embryonic response to stimuli. 
 The same CA-CaMKII overexpressed embryos were assessed for swimming ability at 
48hpf.  The average embryonic swimming ability score for overexpression of CA-CaMK-II 
was 2.06 ± 0.68 for 25pg and 1.74 ± 0.72 for 50pg was statistically significantly different 
from the swimming ability average score of danieau buffer injected embryos of 2.90 ± 0.32 
with both p-values < 0.001. Both 25pg (n = 51) and 50pg (n = 39) showed over 50% and 
40% impaired swimming respectively (Figure 11).  Embryos showed lack of a full C-bend in 
the trunk-and-tail, swam a short distance away from stimuli by quick twitches in the trunk, 
and even showed directional randomness while swimming. The data suggests that 
overexpression of constitutively active CaMK-II in embryos showed significant inhibition of 
response to stimulation and swimming ability, supporting that CaMK-II’s role in skeletal 
muscle intervenes with swimming behavior. 
 Previous results show that ubiquitous expression of WT-CaMK-II and CA-CaMK-II 
resulted in swimming behavior defects. The following experiments used a mutated 
dominant-negative (DN) form of CaMK-II to determine affects on swimming behavior. 
Dominant-negative CaMK-II is made by mutating Lys43 to Ala43 (K43A). Embryos were 
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injected with K43A dominant-negative CaMK-II-GFP-flag tagged ubiquitous expression 
cDNA at the one-to-four cell stage and assessed for their ability to respond to mechanical 
stimuli and swimming ability at 48hpf. Dominant-negative CaMK-II overexpressed embryos, 
25pg (n = 63) and 50pg (n = 42), showed normal morphology and mosaic expression of 
GFP in the trunk and tail at 48hpf (Figure 7k-n).  The average embryonic response to stimuli 
score was 2.16 ± 0.75 for 25pg and 2.27 ± 0.79 for 50pg of DN-CaMK-II was found to be 
significantly different from the average response to stimuli score of danieau buffer injected 
embryos of 2.90 ± 0.32 with both p-values < 0.001. The results show that almost 60% of 
25pg and 30% of 50pg injected embryos showed a delayed response to stimuli (Figure 12). 
As concentration increased, there was a decrease in percentage of delayed response, but 
showed an increase in percentage of embryos that had no response to stimuli (Figure 12). It 
was expected that overexpression of DN CaMK-II would have similar effects to response to 
stimulation as KN-93. The results show that DN CaMK-II expressed embryos had a 
significant inhibited affect on response to stimuli. This outcome suggests overexpression of 
dominant-negative CaMK-II may have a neuronal effect on embryos in either sensory or 
motor neurons. 
 The previous DN-CaMK-II overexpressed embryos were also assessed for 
swimming ability. The average embryonic swimming ability score for DN-CaMK-II was 2.04 
± 0.68 for 25pg and 2.11 ± 0.72 for 50pg was found to be significantly different from the 
average swimming ability score of danieau buffer injected of 2.90 ± 0.32 with both p-values 
< 0.001. Over 60% of 25pg and 50pg injected embryos showed impaired swimming 
behavior.  Embryos exhibiting no swimming ability increased from about 8% to over 20% 
when the concentration increased (Figure 13). Embryonic swimming at 48hpf tended to 
show twitching or spasms of the body upon stimulation.  Embryos displayed slower 
17 
swimming movement as well as lack of a full C-bend. The data shows K43A dominant-
negative CaMK-II overexpression had a significant inhibition on embryonic swimming 
ability, which is consistent with KN-93 treated embryos. The results support the role of 
CaMK-II in skeletal muscle effects on swimming behavior. 
 
Summary of CaMK-II construct injections 
All three CaMK-II constructs (wild type, constitutively active, and dominant-
negative) all exhibited variable level of defects in response to stimuli as well as swimming 
ability. All embryos were scored for GFP expression from 1-5, a score of a 1 indicated the 
lowest expression and a 5 indicated highest GFP expression in the trunk. The study found 
there was no correlation between amount of GFP expressed in the trunk and swimming 
behavior. It should be noted, some embryos that scored a 5 and showed GFP expression in 
the brain region exhibited no response to stimuli and no swimming. The statistical results 
revealed there was no significant difference between average response to stimuli and 
swimming ability scores of CaMK-II cDNA dosage amounts with all p-values > 0.05. The 
only exception was the significant difference in average swimming ability score of 25pg and 
50pg of constitutively active CaMK-II with a p-value = 0.04.  Overexpression of wild-type 
CaMK-II in embryos exhibited the widest range of response and swimming behavior among 
all three constructs. Some WT-CaMK-II overexpressed embryos were able to show a full C-
bend in the trunk and tail, quickly respond to stimuli and demonstrate full bend and counter 
bend of tail with burst swimming.  At the same time other overexpressed wild-type CaMK-II 
embryos showed delayed responses and patterns of impaired swimming. Overexpression of 
constitutively active or dominant-negative CaMK-II embryos showed consistent defects in 
response to stimuli as well as impaired swimming behaviors.  Over 99% of embryos from all 
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three injected constructs showed normal morphology at 48hpf, however some embryos 
failed to respond to any stimulation and demonstrate any swimming ability. 
 
Co-localization of CaMK-II in skeletal muscle with anti-myosin fluorescent 
antibodies 
 It was of interest to determine whether overexpression CaMK-II was tended to 
localize in fast or slow muscle and if there were any defects in either skeletal muscle type 
during development. I addressed the issue by immunostaining CaMK-II-GFP injected 
embryos with one of two primary antibodies, MF20, a fast-twitch skeletal muscle anti-
myosin antibody and F59, a slow-twitch skeletal muscle anti-myosin antibody. Fast-twitch 
muscles are deeper muscles found closer to the notochord whereas slow-twitch muscles are 
more superficial.   
 Wild-type CaMK-II 25pg and 50pg injected embryos were fluorescently labeled for 
fast and slow twitch muscles at 48hpf. The CaMK-II-GFP constructed localize in fast-twitch 
muscle fibers (Figure 14a-f), as was expected based on endogenous total CaMK-II 
localization but endogenous CaMK-II is not constitutively active in fast-twitch muscle 
(Rothschild et al., 2011).  The shape of the GFP expressed muscle strand shows similar 
normal morphological features fast-twitch muscle fibers not expressing GFP (n = 5). The 
muscle striations in the fast-twitch muscle are angled at about 45° from the midline of the 
trunk towards the dorsal or ventral side of the trunk.  Like the GFP expressed muscle cells, 
fast-twitch muscle fibers also showed multi-nucleated syncytia (Figure 14b and e).   
Wild-type CaMK-II was also expressed in similar locations when stained for slow-
twitch muscle, F59.  Slow-twitch muscle fibers did not angle from the midline, were more 
parallel along the trunk, and at higher magnifications showed individual sarcomeres in the 
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muscle fibers (Figure 14g-l).   Although the CaMK-II constructs were ubiquitously expressed 
in the embryo, GFP expression still showed patterns of a fast-twitch muscle fiber (n = 5) 
(Figure 14h and k). The GFP expressed muscle fibers are angled at 45° away from the 
midline and showed the multinucleated syncitia whereas the F59 stained slow-twitch muscles 
are not angled from the midline and do not show multinucleated syncitia. There was no 
dysmorphology of fast or slow twitch muscle development in WT-CaMK-II overexpressed 
embryos. In conclusion, overexpression of wild-type CaMK-II-GFP embryos tended to co-
localize in fast muscle and not slow muscle.  
 Overexpressed T287D constitutively active (CA) CaMK-II-GFP 25pg and 50pg 
injected embryos were also fluorescently labeled for fast and slow-twitch muscles at 48hpf. 
Ectopically expressed CA-CaMK-II embryos were labeled with MF20 and showed co-
localization expression of GFP in fast-twitch muscle (n = 5) (Figure 15a-f).  Fast muscle 
fibers without GFP and those expressing GFP were angled at about 30-40° away from the 
midline and showed multinucleated syncitia.  GFP was expressed fibers showed clear co-
localization in fast-twitch muscle (Figure 15c).  
 Overexpressed constitutively active CaMK-II-GFP embryos were fluorescently 
labeled with F59 for slow-twitch muscle.  The GFP expressed in the muscle of CA-CaMK-II 
overexpressed embryos were angled at about 45° to the midline and showed multinucleated 
syncitia. Whereas, slow-twitch muscle fibers were not angled away from the midline and 
GFP expressed muscle cells did not show the sarcomeres that are seen in normal slow-
twitch fibers (Figure 15g-i). In overexpressed T287D constitutively active CaMK-II embryos 
GFP tended to co-localize in fast muscle and not slow muscle (n = 10). Additionally, CA-
CaMK-II expressed embryos did not show any dysmorphology of muscle fibers.  
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 K43A dominant-negative CaMK-II-GFP expression was assessed in fast and slow-
twitch muscles. After staining with MF20, 25pg and 50pg DN-CaMK-II injected embryos 
showed expression of GFP in fast-twitch fibers. The non-GFP and GFP expressed muscle 
fibers were angled at about 20-30° from the midline. The GFP expressed muscle cells 
showed multinucleated syncitia, which is consistent with non-GFP muscle fibers (Figure 
16a-f).   
Dominant-negative CaMK-II injected embryos were stained with F59. Embryos 
showed expression of GFP in a fast-twitch muscle shape (Figure 16g-l).  In 25pg DN 
injected embryos GFP was expressed in each muscle somite but the GFP muscle strands 
were angled at about 45° from the lateral midline as well as showed muscle nuclei. Slow 
muscle stained fibers do not angle from the midline nor do they show muscle nuclei. 
Overexpression of DN-CaMK-II in embryos tended to co-localize in fast muscle more than 
slow muscle (n = 10). Similar to CA-CaMK-II, the overexpression of dominant-negative 
CaMK-II did not cause any dysmorphology of skeletal muscle during development when 
compared to uninjected embryos (Figure 17a-b). 
 
Assessment of axon development in skeletal muscle  
 Wild-type, T287D constitutively active, and K43A dominant-negative CaMK-II cDNA 
constructs were injected into embryos, fixed, and immunostained for acetylated tubulin (anti-
acetylated α-tubulin) at 48hpf. Anti-acetylated α-tubulin is a marker for sensory and motor 
neuronal axon. All three constructs (WT, CA, and DN) showed similar axonal development 
when compared to uninjected wild-type embryos (n = 20) (Figure 18a-l and Figure 19). The 
results indicate that overexpression of CaMK-II does not have an effect on axonal 
development in muscle somites in the trunk and tail. 
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Inhibition of CaMK-II affects embryonic hatching 
Around 48hpf some untreated and uninjected embryos were able to self-hatch out of 
the chorion prior to touch test. The hatching period for zebrafish embryos is from 48-72hpf 
where individuals within a single developing clutch hatch sporadically during the whole 3rd 
day time frame (Kimmel et al., 1995).  Almost all KN-93 and CaMK-II cDNA injected 
embryos required dechorionation prior to touch test. CaMK-II is involved in biochemical 
signaling secretions. It has been found the overexpression of CaMK-II Leucine/Glutamine-
stimulated insulin secretion (Lee et al., 2009).  It may be possible that inhibition of CaMK-II 
affects hatching enzyme secretion from the hatching gland in zebrafish.  Allowing embryos 
to develop to 72hpf and counting the number of embryos that self-hatched can assess 
CaMK-II’s effects hatching enzyme secretion.  
 
Construction of CaMK-II-GFP cDNA vector with muscle specific promoter 
I. Myogenin promoter PCR amplification and Gateway cloning 
The goal of this study was to target CaMK-II-GFP expression exclusively to skeletal 
muscle and alleviate any issues of skeletal defects versus possible neuronal defects.  The 
objective of this experiment was to link a skeletal muscle specific promoter, myogenin, to 
CaMK-II by Gateway cloning technology (Fontes, 2013).  The obtained, myogenin promoter 
was flanked with att sites and amplified by PCR and successfully recombined into a 5’entry 
vector (Figure 3). The myogenin-5’entry construct underwent a multi-site recombination 
reaction linking together three cDNA constructs: 5’-myogenin promoter, K43A-GFP FLAG-
CaMK-II middle gene of interest, and polyA-3’. Sequencing of the multi-site clones failed to 
show any clear confirmation of recombination of the three entry vector constructs. 
22 
Additional attempts at multi-site reactions were conducted and yielded no further colony 
growth. 
 
Confirmation of myogenin promoter and CaMK-II with PCR 
 Since the multi-site clones failed to show a clear sequence, the objective was to 
confirm the presence of three constructs in the clonal DNA by PCR. PCR amplification of 
the multi-site clone with a GFP forward primer and polyA reverse primer confirmed the 
presence of polyA, CaMK-II, and GFP in the correct orientation. Additionally, PCR 
confirmed the presence of myogenin promoter gene in the multi-site clone DNA. 
 
Injection of multi-site clones (myogenin-K43A-GFP-polyA) 
After confirmation of the construct segments by PCR, embryos were injected with 
the myogenin-DN-CaMK-II-GFP construct and incubated with PTU. At 24hpf, embryos did 
not express any GFP in the trunk indicating that the construct was not functional. It may be 
possible the cDNA construct was out of reading frame. 
 
II. Restriction digestion and ligation of myogenin insert into p5E-mcs vector 
After using gateway technology and failing to produce a skeletal muscle specific 
CaMK-II construct, the next objective was to use a combination of restriction digestion and 
recombination cloning techniques to recombine myogenin into an entry vector followed by 
gateway cloning to construct a skeletal muscle specific CaMK-II expression vector.  Myogenin 
promoter gene segment was successfully removed with Sal restriction endonuclease and 
recombined into a 5’-entry (p5E-mcs) vector, and confirmed with HinDIII digest (Figure 3). 
Directionality was tested with Spe and found that the myogenin insert was recombined into 
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the vector in the 3’ to 5’ orientation. The SalI digest and recombination was repeated and 
failed to yield any further clones.  
Upon further review, it was determined that the myogenin promoter required a 640-
base pair (bp) rabbit β-globin intron, which has been shown to enhance gene expression (Du 
2003). In construction of the myogenin-GFP plasmid there was a mutation mistake, creation 
of an ATG start site within the promoter region. If the ATG site was not eliminated and the 
β-globin intron was excluded, the DNA construct would be left out or reading frame. But if 
the β-globin intron was included, it would leave the DNA construct in proper reading frame. 
 The next objective was to isolate the myogenin promoter gene segment including the 
β-globin intron. Restriction digestion and recombination with SmaI would isolate myogenin 
segment including the β-globin intron and keep the DNA construct in proper reading frame. 
Myogenin promoter - β-globin intron gene segment was successfully isolated with SmaI and 
recombined into a p5E-mcs vector but failed to yield any colonies. The SmaI restriction 
digestion was repeated and recombined into p5E vector but the further recombination 
reactions failed to yield any colonies.  
 
III. Restriction digestion and ligation of K43A insert into myogenin vector 
 The next attempt to link myogenin with CaMK-II was to isolate K43A and recombine it 
into the myogenin expression vector. Using this method would create the construct in a single 
recombination reaction and not rely on multiple gateway cloning reactions. Restriction 
enzymes EcoRI and XbaI were used in a double digest to isolate myogenin and K43A. Myogenin 
double digest was unsuccessful at isolating the myogenin vector without GFP and yielded 
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multiple bands on an agarose gel (Figure 3). K43A was also unsuccessful at isolating the K43A 
insert and yielded multiple bands on an agarose gel.   
 
IV. Future directions with the construction of myogenin-CaMK-II-GFP cDNA 
One of the goals of this study was to target CaMK-II expression in skeletal muscle. 
In this study, the variety recombination methods failed to produce any myogenin-CaMK-II-
GFP clones.  Gateway technology recombination reactions are a low yielding reaction but 
when clones are produced they typically contain all required gene segments in the final 
destination vector.  
It was first suspected there was an issue with the p5E vector, which was later, 
sequenced and confirmed to be the correct vector.  The next issue was questioning the 
transformation technique post digestion and recombination.  As a control transformation, 
the 5’entry vector was transformed by itself, which produced no colonies, when in theory, 
colonies should have grown.  
The future direction of construction of myogenin-CaMK-II cDNA would be to 
continue using either restriction recombination or gateway cloning to build the construct.  
The results show myogenin promoter gene segment can undergo a gateway reaction into an 
entry vector. The next step would be to construct a reverse primer for myogenin that would 
include 640-bp rabbit β-globin intron and PCR amplification followed by a gateway reaction 
into the pDONR vector. 
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DISCUSSION 
 
 
 
In this study, I provide evidence that CaMK-II is necessary for proper swimming 
behavior in zebrafish embryos. This conclusion was determined through the use of 
pharmacological and genetic intervention and reinforced by immunolocalization of CaMK-II 
and skeletal muscle. 
CaMK-II has many functional and developmental roles in many model organisms 
and has generally been associated with the central nervous system (Schulman et al., 1992). 
CaMK-II studies have defined it as a key kinase molecule in muscle excitation-contraction 
coupling and relaxation of cardiac and skeletal muscle (Maier and Bers, 2007; Sacchetto et 
al., 2005).  This study concludes that inhibition of CaMK-II in skeletal muscle diminishes 
normal swimming behavior specifically in response to stimulation and swimming ability. 
Zebrafish CaMK-II enzymatic activity is relatively stable between 4 and 12hpf, but increases 
by 100 fold from 12 to 48hpf (Rothschild et al., 2007). CaMK-II expression in the trunk is 
not found in early stages post-fertilization. CaMK-II genes camk2b1, camk2g1, and camk2g2 
have increased expression in the trunk from 18-somite stage and are strongly expressed at 
24hpf (Rothschild et al., 2007). The results suggest inactivity of CaMK-II during the time 
points of increased trunk expression will have behavioral swimming defects at 48hpf. The 
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findings support that impaired behavioral swimming is due to inhibition of CaMK-II. I 
suspect that this is due to a lack of proper excitation-contraction coupling and relaxation. 
Transient CaMK-II inhibition does not have any long-term defects on embryonic 
response to stimuli. KN-93 is shown to have an inhibitory effect on the glial cell migration 
and axon development (Lohr et al., 2007).  Embryos were allowed to develop normally to 
43hpf prior to treatment which would allowed for proper development of axons and verify 
any behavioral defects seen at 48hpf would be exclusively functional and not developmental.  
The evidence suggests, inactivation of CaMK-II by KN-93 has minimal functional effects on 
sensory neurons when treated at 43hpf.  
Transient CaMK-II inhibtion has a functional effect on embryonic swimming ability 
without long-term deficiencies. CaMK-II plays many roles in skeletal muscle including 
recycling nicotinic acetylcholine receptors at neuromuscular junctions, release and re-uptake 
of Ca2+ in the sarcomere (Valenuela et al., 2010; Maier and Bers, 2007) (Figure 1). CaMK-II 
inactivation in muscle fibers would lead to sarcomeres not receiving proper signaling for 
excitation-contraction coupling in skeletal and cardiac muscles.  Inactivity of CaMK-II by 
KN-93 treatment may have inhibited the ability for embryos to fully contract both fast and 
slow muscles. Additionally, drug treated embryos would have inhibited ability to relax slow 
muscle fibers. Treated embryos displayed minimal lateral trunk-and-tail flexing with constant 
twitches to swim away from the stimuli. The data suggests behavior is due to CaMK-II’s role 
in phosphorylating Ca2+ handlers in the sarcomere of skeletal muscle (Figure 1). CaMK-II 
inactivity did not have long-term effects on zebrafish swimming ability. As results 
demonstrated, pharmacologically treated embryos showed recovery to normal swimming 
post washout.  This result is consistent with previous research on KN-93 effects in 
zebrafish.  It has been reported that KN-93 treated embryos showed a reduction in heart 
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rate and within one hour of KN-93 washout, embryos demonstrated complete recovered 
heart rate (Rothschild et al., 2013). Embryos were not able to fully recover swimming ability 
a few hours post washout as seen in heart rate recoverability. This is due to the larger 
presence of skeletal muscle within the embryo compared to cardiac muscle, which means an 
increased time of recovery for skeletal muscle is required compared to cardiac muscle.  
Additionally this study showed normal burst swimming is attributed to fast-twitch muscle, 
which was largely affected by CaMK-II inhibition, whereas cardiac muscle is composed of 
slow muscle. 
Inactivation of CaMK-II prevents relaxation of skeletal muscle in the trunk-and-tail 
of zebrafish embryos.  It was observed at 48hpf that KN-93 treated embryos were in a 
locked curved tail position post dechorionation. Curved tail morphologies have been 
attributed to gastrulation defects, but embryos treated post-grastrulation phase as early as 
12hpf and as late as 43hpf all showed locked curved tail morphology (Hammerschmidt et al., 
1996).  It is possible the curved tail may be due to the position of the embryo within the 
chorion, but the embryos upon stimulation would twitch and return to the locked tail 
position.  The reason is unknown but lacking the ability to fully relax muscles along the 
trunk and tail due to inactivation of CaMK-II is a contributing factor. 
I showed that pharmacological treatment of embryos inhibiting CaMK-II activity 
leads to swimming ability defects.  In addition, ubiquitous CaMK-II cDNA expression in 
embryos has an effect on behavioral swimming, specifically the response to stimulation and 
swimming ability. Expression of wild-type CaMK-II had an effect on embryonic ability to 
respond to stimuli and swimming ability. This was not the expected behavioral phenotype 
considering wild-type CaMK-II allows for the embryo to activate or inactivate CaMK-II as 
needed.  Although it was wild-type CaMK-II in the embryo, it was still ubiquitously 
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expressed throughout the embryo and not exclusively skeletal muscle. The ubiquitous 
expression makes CaMK-II more prevalent and available for all cell types to use. Due to 
CaMK-II multi-functional capabilities it was unknown upon time of mechanical stimulation, 
expression of CaMK-II outside of skeletal muscle, such as cardiac or CNS, may have 
contributed to swimming behavioral defects observed at 48hpf (Tombes et al., 2003). 
I found that ubiquitous expression of a mutated form of CaMK-II impairs 
swimming behavior as well.  Expression of T287D constitutively active CaMK-II had an 
effect on embryonic ability to respond to stimuli and swimming ability. Ryanodine receptors, 
a SR-bound phosphorylated protein of CaMK-II, would have continuous release of Ca2+ 
into the sarcomere forcing the muscles to remain in a contracted state. Phospholamban, a 
phosphorylated protein of CaMK-II and SERCA inhibitor, would continuously be unbound 
from SERCA allowing for the constant reuptake of Ca2+ into the SR leading to constant 
relaxation state only in some slow-twitch muscle (Maier and Bers, 2007) (Figure 1). Normal 
skeletal muscle function is dependent on the complete cycle of excitation-contraction 
coupling and relaxation (Froemming et al., 2001).  
The inhibition of CaMK-II activity by pharmacological treatment or genetic 
intervention leads to impaired swimming behavior possibly through defects in excitation-
contraction coupling and relaxation. Expression of K43A dominant-negative CaMK-II had 
an effect on embryonic ability to respond to stimuli and swimming ability.  Expression of 
dominant-negative CaMK-II may act antagonistically on wild-type cells.  It is believed that 
the mutated form of CaMK-II affected potential function of phosphorylated proteins in 
skeletal muscle. Nicotinic acetylcholine receptor is dependent on functional CaMK-II for 
receptor cycling at neuromuscular junctions. Any inhibition of CaMK-II will delay the rate 
or even halt nAChR cycling which leads to lack of signaling in muscle (Valenuela et al., 
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2010).  Like KN-93 treatment, ryanodine receptors in GFP expressed muscle would not 
have Ca2+ release for proper muscle contraction.  The results support CaMK-II as a vital 
enzymatic protein involved in swimming behavior of zebrafish and that it’s multiple roles in 
excitation-contraction coupling plays a key position in skeletal muscle function regarding 
swimming ability. 
All three CaMK-II constructs (WT, T287D-CA, and K43A-DN) showed expression 
and co-localization of CaMK-GFP in fast-twitch muscle and not slow-twitch muscle, which 
led to defects in burst swimming. At 24hpf, coiling behavior of muscles is exclusively slow-
twitch muscle only, whereas any burst swimming at 48hpf is executed by primarily fast-
twitch muscle (Naganawa and Hirata, 2011).  If fast-twitch muscles are inhibited, embryos 
are left with only full functional slow-twitch fibers. The slow muscle is capable of propelling 
embryos away from stimuli but at a “slow swimming” pace.  The use of exclusively slow-
twitch fibers may explain the lack of not just burst swimming but distance traveled away 
from stimuli as well. Morphology of all three injected constructs did not show any 
dysmorphological features in myosin of fast and slow-twitch muscles. But has yet to be 
determined if there were defects in filamentous actin of skeletal muscle. Previous research 
showed lack of burst swimming at 48hpf is due to disorganization of filamentous actin 
found in the trunk in flightless (Fli-I) mutants (Naganawa and Hirata, 2011). It has been 
reported that CaMK-II is a regulator of Fli-I for β-catenin transcription (Seward et al., 2008). 
It may be possible CaMK-II regulates Fli-I in embryonic actin of muscle tissue.  
The results establish an important role of CaMK-II in skeletal muscle function and 
swimming behavior of embryonic zebrafish. There are many directions this research can go 
in the future. Due to the time point of this study’s behavioral testing, CaMK-II’s behavioral 
effects were observed mainly by fast muscle. In order to fully understand CaMK-II’s role in 
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slow muscle, behavioral testing can be conducted at 24hpf in which any swimming and 
coiling behavior is exclusively slow muscle (Naganawa and Hirata, 2011). Although burst 
swimming is attributed by slow and fast twitch muscle at 48hpf, it is majority fast muscle 
functioning for burst swimming. Previous research found that when slow muscle was 
knocked down in zebrafish it did not affect burst swimming at 48hpf (Naganawa and Hirata, 
2011). In order to fully observe CaMK-II’s behavioral capabilities of the trunk-and-tail, 
embryos at 24hpf and 48hpf can be pinned down leaving the tail to move freely. Embryos 
can be video recorded for swimming flexion. Video frames can be superimposed and 
provide a quantitative measurement for lateral flexing (Naganawa and Hirata, 2011). The 
future of this study can also evaluate any neuronal roles of CaMK-II. CaMK-II cycling of 
nAChRs has been shown in mammalian neuromuscular junctions but hasn’t been seen in 
zebrafish.  Fluorescently conjugated α-bungarotoxin is an immunostain used in zebrafish as 
a marker for neuromuscular synapses including AChRs may be used to determine if CaMK-
II expression in the trunk keeps a high density of nAChRs in embryonic zebrafish (Panzer et 
al., 2005).  Previous research on mutated ryanodine receptor, a SR-bound CaMK-II 
phosphorylated protein, has been linked to rare muscle myopathies called multi-minicore 
disease and central core disease, which are an inherited neuromuscular disorder characterized 
by multiple cores on muscle biopsies (Jungbluth, 2007a; Jungbluth, 2007b).  CaMK-II can be 
linked to these diseases and can be tested by electron micrographs of fast muscles showing 
SR (Hirata et al., 2007). Fast muscle cross section electron micrographs of ryanodine mutant 
zebrafish exhibit amorphous cores and SR are disorganized (Hirata et al., 2007). 
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Figure 1. The role of CaMK-II in excitation-contraction coupling and relaxation. 
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Figure 2. Mechanical touch test of untreated embryo at 48hpf. 
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Figure 3. Myogenin promoter construct map.  
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Figure 4. Effects of KN-93 continuous treatment on embryonic swimming ability at 
various time points. Embryos were treated at time points starting between 13hpf to 43hpf 
(n = 313) and continuing to 48hpf. At 48hpf embryos were dechorionated prior to 
assessment for swimming ability by touch test.  All statistical analyses were completed by 
unpaired t-test. Statistical significance was set at p < 0.05. The average scores of each time 
point were 3.00 ± 0.00 for untreated, 1.92 ± 0.28 at 13hpf, 1.88 ± 0.39 at 23hpf, 1.79 ± 0.41 
at 28hpf, 1.89 ± 0.36 at 37hpf, and 1.95 ± 0.22 at 43hpf.  The average swimming ability 
score of KN-93 treatment embryos at all time points (13-43hpf) were statistically 
significantly different from untreated embryos with all p-values < 0.001. 
 
 
 
 
 
 
 
0%	  10%	  
20%	  30%	  
40%	  50%	  
60%	  70%	  
80%	  90%	  
100%	  
Fi
sh
	  C
ou
nt
	  (%
)	  
Time	  At	  Which	  KN-­‐93	  Treatment	  Started	  
Swimming	  Ability	  
Normal	  Swimming	  Impaired	  Swimming	  No	  Swimming	  
35 
 
 
 
 
 
 
 
Figure 5. Effects of KN-93 wash on embryonic ability to respond to mechanical 
stimuli. The treated group was embryos that were treated at 43hpf and remained in solution 
(n = 20). The wash group was embryos that were treated at 43hpf and washed at 45hpf (n = 
28).  All groups were assessed for response by touch test at 48hpf. All statistical analyses 
were completed by unpaired t-test. Statistical significance was set at p < 0.05. The average 
response to stimuli score for untreated embryos was a score of a 3.00 ± 0.00, treated 
embryos was a 2.75 ± 0.55, and washed embryos was a 2.82 ± 0.48. Continuously treated 
embryos did not show statistical significant difference in ability to respond to stimuli 
compared to untreated embryos with a p-value = 0.06.  The average score for embryos 
washed out at 45hpf did not show statistical significant difference in ability to respond to 
stimuli at 48hpf compared to treated embryos that were not washed at 45hpf with a p-value 
= 0.64. 
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Figure 6. Effects of KN-93 wash on embryonic swimming ability. The treated group 
was embryos that were treated at 43hpf and remained in solution (n = 20). The wash group 
was embryos that were treated at 43hpf and washed at 45hpf (n = 28). All groups were 
assessed for swimming ability by touch test at 48hpf. All statistical analyses were completed 
by unpaired t-test. Statistical significance was set at p < 0.05. The average swimming ability 
score for untreated embryos was 3 ± 0, treated embryos was 1.95 ± 0.22, and washed 
embryos was 2.55 ± 0.58. The data showed there was statistical significant difference in 
average swimming ability score between treated and untreated embryos with a p-value 
<0.001. The results indicate there was a significant recovery in swimming ability when KN-
93 was washed out after two hour treatment. 
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Figure 7. Embryos were assessed for GFP expression at 48hpf after injection of 
CaMK-II-GFP tagged cDNA constructs. Differential interference contrast and 
fluorescent images were taken on cDNA injected embryos at 48hpf.  Uninjected embryos 
developed to 48hpf prior to behavioral test (a-b). Embryos were injected with CaMK-II-
GFP at two amounts 25pg and 50pg: (c-f) Wild-type (WT), (g-j) T287D constitutively active 
(CA), and (k-n) K43A dominant-negative. 
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Figure 8. Effects of overexpressed wild-type CaMK-II on embryonic ability to 
respond to stimuli. Embryos were injected with 25pg (n = 57) and 50pg (n = 44) of wild-
type (WT) CaMK-II at the one-to-four cell stage and assessed for ability to respond to 
stimuli by touch test at 48hpf. All statistical analyses were completed by unpaired t-test. 
Statistical significance was set at p < 0.05. The average response to stimuli score for wild-
type overexpression was 2.90 ± 0.32 for danieau buffer, 2.25 ± 0.59 for 25pg, and 2.29 ± 
0.81 for 50pg. The statistical results show that there was a significant difference between 
both 25pg and 50pg of overexpressed wild-type CaMK-II compared to danieau buffer 
injected embryonic response to stimuli with both p-values <0.001.   
 
 
 
 
 
 
 
 
 
 
 
 
0%	  10%	  
20%	  30%	  
40%	  50%	  
60%	  70%	  
80%	  90%	  
100%	  
Danieau	  Buffer	   25pg	  WT	   50pg	  WT	  
Fi
sh
	  C
ou
nt
	  (%
)	  
Wild-­‐type	  CaMK-­‐II	  injection	  Amounts	  
Response	  to	  Mechanical	  Stimuli	  
Normal	  Response	  Delayed	  Response	  No	  Response	  
39 
 
 
 
 
 
 
 
Figure 9. Effects of overexpressed wild-type CaMK-II cDNA on embryonic 
swimming ability. Embryos were injected with 25pg (n = 57) and 50pg (n = 44) of wild-
type (WT) CaMK-II at the one-to-four cell stage and assessed for ability to swim by touch 
test at 48hpf. All statistical analyses were completed by unpaired t-test. Statistical significance 
was set at p < 0.05. The average swimming ability score when wild-type CaMK-II is 
overexpressed was 2.90 ± 0.32 for danieau buffer, 2.24 ± 0.59 for 25pg, and 1.90 ± 0.58 for 
50pg. The statistical results show that there is a significant difference between both 25pg and 
50pg wild-type CaMK-II compared to danieau buffer injected embryos with both p-values 
<0.001. 
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Figure 10. Effects of overexpressed constitutively active CaMK-II on embryonic 
ability to respond to stimuli. Embryos were injected with 25pg (n = 51) and 50pg (n = 39) 
of constitutively active (CA) CaMK-II at the one-to-four cell stage and assessed for ability to 
respond to stimuli by touch test at 48hpf. All statistical analyses were completed by unpaired 
t-test. Statistical significance was set at p < 0.05. The average response to stimuli scores for 
overexpression of CA-CaMK-II was 2.12 ± 0.71 for 25pg and 1.87 ± 0.86 for 50pg were 
found to be statistically significantly different from the control injection of danieau buffer 
score of 2.90 ± 0.32 with both p-values < 0.001. 
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Figure 11. Effects of overexpressed constitutively active CaMK-II on embryonic 
swimming ability. Embryos were injected with 25pg (n = 51) and 50pg (n = 39) of 
constitutively active (CA) CaMK-II at the one-to-four cell stage and assessed for ability to 
swim by touch test at 48hpf. All statistical analyses were completed by unpaired t-test. 
Statistical significance was set at p < 0.05. The average embryonic swimming ability score for 
overexpression of CA-CaMK-II was 2.06 ± 0.68 for 25pg and 1.74 ± 0.72 for 50pg was 
statistically significantly different from the swimming ability average score of danieau buffer 
injected embryos of 2.90 ± 0.32 with both p-values < 0.001. 
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Figure 12. Effects of overexpressed K43A dominant-negative CaMK-II on embryonic 
ability to respond to stimuli. Embryos were injected with 25pg (n = 63) and 50pg (n = 42) 
of K43A dominant-negative CaMK-II at the one-to-four cell stage and assessed for ability to 
respond to stimuli by touch test at 48hpf. All statistical analyses were completed by unpaired 
t-test. Statistical significance was set at p < 0.05. The average embryonic response to stimuli 
score was 2.16 ± 0.75 for 25pg and 2.27 ± 0.79 for 50pg of DN-CaMK-II was found to be 
significantly different from the average response to stimuli score of danieau buffer injected 
embryos of 2.90 ± 0.32 with both p-values < 0.001. 
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Figure 13. Effects of injected K43A dominant-negative CaMK-II on embryonic 
swimming ability. Embryos were injected with 25pg (n = 63) and 50pg (n= 42) of K43A 
dominant-negative CaMK-II at the one-to-four cell stage and assessed for ability to swim by 
touch test at 48hpf. All statistical analyses were completed by unpaired t-test. Statistical 
significance was set at p < 0.05. The average embryonic swimming ability score for DN-
CaMK-II was 2.04 ± 0.68 for 25pg and 2.11 ± 0.72 for 50pg was found to be significantly 
different from the average swimming ability score of danieau buffer injected of 2.90 ± 0.32 
with both p-values < 0.001. 
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Figure 14.  Co-localization of overexpressed wild-type CaMK-II-GFP cDNA 
expression in skeletal muscle. The expression of wild-type CaMK-II GFP was assessed in 
fast and slow-twitch muscles (Alexa 568, red) at 48hpf by confocal microscopy. Fast-twitch 
muscle (MF20) was fluorescently labeled in 25pg and 50pg WT-CaMK-II embryos (a-f). 
Slow-twitch muscle (F59) was fluorescently labeled in 25pg and 50pg WT-CaMK-II embryos 
(g-l).  
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Figure 15. Co-localization of overexpressed T287D constitutively active CaMK-II-GFP 
cDNA expression in skeletal muscle. The expression of T287D constitutively active 
CaMK-II GFP was assessed in fast and slow-twitch muscles (Alexa 568, red) at 48hpf by 
confocal microscopy. Fast-twitch muscle (MF20) was fluorescently labeled in 25pg and 50pg 
CA-CaMK-II embryos (a-f). Slow-twitch muscle (F59) was fluorescently labeled in 25pg and 
50pg CA-CaMK-II embryos (g-l).  
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Figure 16. Co-localization of overexpressed K43A dominant-negative CaMK-II-GFP 
cDNA expression in skeletal muscle. The expression of K43A dominant-negative CaMK-
II GFP was assessed in fast and slow-twitch muscles (Alexa 568, red) at 48hpf by confocal 
microscopy. Fast-twitch muscle (MF20) was fluorescently labeled in 25pg and 50pg DN-
CaMK-II embryos (a-f). Slow-twitch muscle (F59) was fluorescently labeled in 25pg and 
50pg DN-CaMK-II embryos (g-l).  
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Figure 17. Fluorescent labeling of uninjected embryos in skeletal muscle. Skeletal 
muscle morphology was assessed in uninjected embryos. Fast-twitch muscle was 
fluorescently labeled with MF20 and slow-twitch muscle was fluorescently labeled with F59. 
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Figure 18.  Immunostaining of acetylated tubulin in the trunk with co-expression of 
CaMK-II-GFP. CaMK-II-GFP injected embryos were fixed and immunostained for 
acetyated tubulin (anti α-tubulin, Alexa 568, Red) at 48hpf.  25pg and 50pg Wild-type 
embryos were fluorescently labeled with anti α-tubulin (a-f). 25pg and 50pg constitutively 
active embryos were fluorescently labeled with anti α-tubulin (g-l). 25pg and 50pg dominant-
negative CaMK-II embryos were fluorescently labeled with anti α-tubulin. 
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Figure 19. Immunostaining of acetylated tubulin in the trunk of uninjected wild-type 
embryos.  Embryos were fixed and fluorescently labeled with anti-acetylated α tubulin at 
48hpf. 
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